Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB26FX1KV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,750
Award facts
- Contract value 100% obligated
- $48,749.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $48,749.85 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, was made without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. will perform the work at its Park Ridge facility and will serve as the sole prime contractor with no identified subcontractors involved in this delivery order.
This delivery order was issued under DMS Pharmaceutical Group's recently awarded Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy designed to support Department of Defense pharmaceutical supply needs globally. The parent IDC, valued at $499.999 billion with a completion date of December 31, 2036, authorizes the company to supply a broad range of pharmaceutical products including branded and generic medications, biologics, and medical consumables to military healthcare facilities worldwide. This delivery order represents one of numerous orders DMS Pharmaceutical Group has fulfilled for the DLA's Medical Supply Chain division, demonstrating the company's established performance in meeting specialized pharmaceutical requirements for federal military medical operations.
Quick answers
Who was awarded contract SPE2DB26FX1KV?
SPE2DB26FX1KV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FX1KV worth?
The government has obligated $48,750 on SPE2DB26FX1KV.
Is contract SPE2DB26FX1KV an order under another contract?
Yes. SPE2DB26FX1KV is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB26FX1KV competed?
The extent of competition for SPE2DB26FX1KV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award